A prospective, randomized, multicenter and phase 3b study to evaluate the efficacy of terlipressin and albumin in cirrhotic patients with ascites and acute kidney injury (AKI)in the range of serum creatinine between 1.5mg and 2.5mg/dL:interim analysis